SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 128 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2015. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $32,000 | -11.1% | 17,417 | +7.8% | 0.00% | – |
| Q4 2017 | $36,000 | -37.9% | 16,153 | +23.7% | 0.00% | – |
| Q2 2017 | $58,000 | +5.5% | 13,054 | +10.5% | 0.00% | – |
| Q1 2017 | $55,000 | -57.4% | 11,810 | -44.4% | 0.00% | -100.0% |
| Q4 2016 | $129,000 | +4.9% | 21,252 | -4.9% | 0.00% | 0.0% |
| Q3 2016 | $123,000 | +115.8% | 22,346 | +48.0% | 0.00% | – |
| Q2 2016 | $57,000 | -9.5% | 15,097 | -33.7% | 0.00% | -100.0% |
| Q1 2016 | $63,000 | -33.0% | 22,760 | +37.7% | 0.00% | 0.0% |
| Q4 2015 | $94,000 | +64.9% | 16,531 | +53.0% | 0.00% | 0.0% |
| Q3 2015 | $57,000 | – | 10,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
| Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
| Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
| Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
| Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
| Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
| Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
| CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
| KNOTT DAVID M | 158,400 | $459,000 | 0.20% |